Aussie pharmaceuticals company Acrux (ASX: ACR) is quickly making inroads through the lucrative American healthcare system with regulatory approval granted for their generic equivalent of a common testosterone topical solution which generates more than $25 million annually. Approval was granted from the Food and Drug administration for Acrux’s gel following their submission in August 2018
Read MoreIs the notion of the typical Australian stacking on the ‘isobars’ and indulging in a few too many ‘lockdown lagers’ during their in-house detention just another case of fake news? In reality, says Healthia (ASX: HLA) CEO Wesley Coote, incarcerated citizens were more likely to be exercising more often and assiduously holding to their appointments
Read MorePediatric healthcare company Nutritional Growth Solutions (ASX: NGS) is set to significantly increase their exposure to the lucrative US healthcare products market, securing a distribution agreement that will see more than 1,000 sales representatives begin pushing NGS products. The agreement is with leading US medical distributor cooperative IMCO, INC which distributes healthcare products through home
Read MoreArtificial intelligence continues to emerge as the driving force behind healthcare and when pitted against 157 actual human dermatologists, this technology beat 98% of them in a diagnosis test. It’s why healthtech company MyFiziq (ASX: MYQ) is integrating it into their app. The tech itself is developed by Canadian company Triage Technology and can identify
Read MoreHealthia (ASX: HLA) shareholders have voted with their wallets firmly in favour of the allied healthcare provider’s expansion into optometry with the Company successfully raising $13.2m from an Entitlement Offer to fund their acquisition of The Optical Company (TOC). The $13.2m from shareholders forms part of the $43m acquisition to proceed, adding 41 optometry clinics
Read MoreLeading allied healthcare company Healthia (ASX: HLA) is set to significantly increase their services and national footprint with the $43 million acquisition of optometry group The Optical Company and their 41 clinics. The acquisition is a horizontal expansion for Healthia which has primarily operated in the podiatry and physiotherapy sectors while also owning iOrthotics, Australia’s
Read More